MedPath

The effect of a synbiotic (probiotic and prebiotic) supplementation on patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A proof of concept study

Early Phase 1
Recruiting
Conditions
on-Alcoholic Fatty Liver Disease
Registration Number
SLCTR/2018/042
Lead Sponsor
Durdans Hospital, 3, Alfred place, Colombo 3
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Subjects who are diagnosed to have NAFLD by a medical officer or a medical consultant [based on hepatic ultrasonography and elevated levels (>1.5xUpper Limit) of alanine aminotransferase (ALT) concentration] and are referred to a registered Dietician & Nutritionist.

Age between 30-55 years

Exclusion Criteria

Subjects having other acute or chronic liver diseases of other etiologies (viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, hereditary haemochromatosis, Wilson's disease, drug induced liver injury; cholestasis).

Subjects who are pregnant and / or lactating

Subjects who have history of malignancy, history of significant alcohol consumption (>14 units/week for men, >7 units/week for females)

Subjects who are taking antibiotics, probiotics, vitamin, mineral, antioxidants, omega-3 or any other food supplements preceding enrollment

Subjects who are on treatment with vitamin E, statins within 3 months prior to the starting date of the research.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in levels of Aspartate Transaminase (AST), Alanine Transaminase (ALT) and Gamma Glutamyl Transpeptidase (GGT). [At the baseline of the study and at 8 weeks]<br>
Secondary Outcome Measures
NameTimeMethod
Change in weight and BMI. <br>Change in dietary measures (assessed using 24-h dietary recalls and semi quantitative food frequency questionnaire)<br>Change in physical activity ( assessed using Short Form of the International Physical Activity Questionnaire.<br> [At the baseline of the study and at 8 weeks]<br>
© Copyright 2025. All Rights Reserved by MedPath